Today's Wound Clinic - Winter 2008 - (Page Cover4) H O W T O M A K E S U R E Y O U W O N ’ T H AV E T O U S E A P L I G R A F T O S A V E T H E F O O T: ® use apligraf heal wound. to the When conventional treatment is not leading to wound closure, Apligraf is a reliable, proven way to achieve more rapid and effective wound healing.1,2 Apligraf is the only wound care product FDA-approved for healing both diabetic foot ulcers and venous leg ulcers. It’s also the only therapy made from two types of living cells, which provide the wound with a healing supply of growth factors. And Apligraf is easily incorporated into your practice, with a 10-day shelf life and support services such as training workshops, reimbursement support and guaranteed delivery. So now there is no reason not to rely on Apligraf to heal the wound. For clinical and other product information, call 888-HEAL-2-DAY (888-432-5232). www.apligraf.com 1. Boulton AJM, Kirsner RS, Vileikyte I. Neuropathic diabetic foot ulcers. N Engl J. Med. 2004;251:48-55. 2. Dove C, Sheehan P. An open-label, multicenter study evaluating the efficacy and safety of bilayered cell therapy in the treatment of diabetic foot ulcers. Hospital for Joint Diseases and NYU School of Medicine, New York, NY. Clinical Symposium on Advances in Skin and Wound Care, October 2005. Please see Apligraf Essential Prescribing Information on reverse side. Apligraf is a registered trademark of Novartis Pharmaceuticals Inc. © 2007 Organogenesis, Inc. All rights reserved. http://www.apligraf.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.